Pillar Biosciences Receives CMS Coverage for FDA Approved oncoReveal® CDx Pan-Cancer Solid tumor IVD Kit
April 3, 2025 – Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced they have received nationwide Medicare coverage by the Centers for Medicare & Medicaid Services (CMS) for oncoReveal® CDx pan-cancer solid tumor in vitro diagnostic (IVD) NGS kit. oncoReveal® CDx is a NGS based IVD kit that uses Pillar’s proprietary SLIMamp (Stem-Loop […]